Mersana Therapeutics Correlations

MRSN Stock

USD 0.64 0.05 8.47%

The current 90-days correlation between Mersana Therapeutics and Acumen Pharmaceuticals is 0.21 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mersana Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mersana Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Mersana Therapeutics Correlation With Market

Average diversification

The correlation between Mersana Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mersana Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mersana Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Mersana Stock, please use our How to Invest in Mersana Therapeutics guide.

Moving together with Mersana Stock

0.68	INZY	Inozyme Pharma	Pair Corr
0.86	KRYS	Krystal Biotech	Pair Corr
0.7	MREO	Mereo BioPharma Group	Pair Corr
0.63	PDSB	PDS Biotechnology Corp	Pair Corr
0.82	PLRX	Pliant Therapeutics	Pair Corr
0.71	ABOS	Acumen Pharmaceuticals	Pair Corr
0.79	AFMD	Affimed NV	Pair Corr
0.81	AGIO	Agios Pharm	Pair Corr
0.81	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.75	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.86	STOK	Stoke Therapeutics	Pair Corr
0.87	TERN	Terns Pharmaceuticals Buyout Trend	Pair Corr
0.82	CRVS	Corvus Pharmaceuticals	Pair Corr
0.7	DAWN	Day One Biopharmaceu	Pair Corr

Moving against Mersana Stock

0.68	MLAB	Mesa Laboratories Earnings Call This Week	Pair Corr
0.37	INKT	Mink Therapeutics	Pair Corr
0.52	BPMC	Blueprint Medicines Corp Sell-off Trend	Pair Corr
0.7	MNPR	Monopar Therapeutics	Pair Corr
0.65	AVAL	Grupo Aval	Pair Corr
0.54	FNMFO	Federal National Mortgage	Pair Corr
0.53	CIB	Bancolombia SA ADR	Pair Corr
0.43	ITCL	Banco Ita Chile	Pair Corr

Related Correlations Analysis

	TERN	AMLX	ABOS	INZY	XFOR	DAWN	HOOK	THRX	CGEM	RLAY
TERN		0.76	0.78	0.85	0.01	0.76	0.7	0.6	0.79	0.6	TERN
AMLX	0.76		0.91	0.71	-0.35	0.9	0.8	0.54	0.85	0.7	AMLX
ABOS	0.78	0.91		0.85	-0.24	0.91	0.94	0.54	0.95	0.87	ABOS
INZY	0.85	0.71	0.85		0.06	0.76	0.82	0.6	0.9	0.74	INZY
XFOR	0.01	-0.35	-0.24	0.06		-0.2	-0.26	-0.07	-0.13	-0.14	XFOR
DAWN	0.76	0.9	0.91	0.76	-0.2		0.88	0.43	0.92	0.84	DAWN
HOOK	0.7	0.8	0.94	0.82	-0.26	0.88		0.42	0.94	0.91	HOOK
THRX	0.6	0.54	0.54	0.6	-0.07	0.43	0.42		0.53	0.34	THRX
CGEM	0.79	0.85	0.95	0.9	-0.13	0.92	0.94	0.53		0.87	CGEM
RLAY	0.6	0.7	0.87	0.74	-0.14	0.84	0.91	0.34	0.87		RLAY
	TERN	AMLX	ABOS	INZY	XFOR	DAWN	HOOK	THRX	CGEM	RLAY

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CGEM	+ 0.95	ABOS
HOOK	+ 0.94	ABOS
CGEM	+ 0.94	HOOK
CGEM	+ 0.92	DAWN
ABOS	+ 0.91	AMLX
DAWN	+ 0.91	ABOS

High negative correlations

XFOR	- 0.35	AMLX
HOOK	- 0.26	XFOR
XFOR	- 0.24	ABOS
DAWN	- 0.2	XFOR
RLAY	- 0.14	XFOR
CGEM	- 0.13	XFOR

Risk-Adjusted Indicators

There is a big difference between Mersana Stock performing well and Mersana Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mersana Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TERN	3.11	(0.64)	0.00	1.10	0.00	0.00	5.17	(6.75)	26.61
AMLX	3.80	(0.50)	0.00	(0.37)	0.00	0.00	7.40	(8.97)	20.49
ABOS	3.41	(0.84)	0.00	(0.79)	0.00	0.00	7.36	(7.10)	24.44
INZY	4.18	(1.67)	0.00	(5.68)	0.00	0.00	6.82	(8.75)	38.13
XFOR	8.67	1.66	0.10	(0.86)	10.83	(12.10)	32.50	(13.51)	67.48
DAWN	1.94	(0.16)	0.00	(0.35)	0.00	0.00	4.00	(3.46)	11.05
HOOK	3.68	(0.82)	0.00	1.17	0.00	0.00	6.51	(7.88)	32.80
THRX	5.44	(0.65)	0.00	(0.50)	0.00	0.00	11.75	(8.57)	90.33
CGEM	2.93	(0.51)	0.00	(3.76)	0.00	0.00	5.13	(7.10)	17.21
RLAY	3.49	(0.43)	0.00	(0.57)	0.00	0.00	7.42	(7.87)	24.83

Mersana Therapeutics Corporate Management

Chuck Miller	Senior Affairs	Profile
Carla Poulson	Chief Officer	Profile
Marc Damelin	Oncology, Biology	Profile
Jason Fredette	Senior Communications	Profile
Mohan Bala	Senior Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC